ArticleBMC cancer2023

Persistence to extended adjuvant endocrine therapy following Breast Cancer Index (BCI) testing in women with early-stage hormone receptor-positive (HR +) breast cancer.

Julia Foldi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.